On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Natimab Therapeutics SRL's own share of each project, not the project's full budget.
- Horizon 2020€50k · 1 project
- FP7 (2007 to 2013)€45k · 1 project
Projects
2 EU-funded projects, newest first. Natimab Therapeutics SRL led 1 of them as coordinator. Each links to the official record.
- EDePDACCoordinator
Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA
Horizon 2020 · 2015–2015 · Project on CORDIS ↗
€50ktheir share - EPC-TM-NETPartner
Targeting the tumour microenvironment to improve pancreatic cancer prognosis
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€45ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Technische Universitaet MuenchenGermany · 1 shared project
- Karolinska InstitutetSweden · 1 shared project
- The University of LiverpoolUnited Kingdom · 1 shared project
- Universita Degli Studi di TorinoItaly · 1 shared project
- Klinikum der Technischen Universität München (Tum Klinikum)Germany · 1 shared project
- Universita Degli Studi di VeronaItaly · 1 shared project
- Philipps Universitaet MarburgGermany · 1 shared project
- Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos IiiSpain · 1 shared project
- Universitaet GreifswaldGermany · 1 shared project
- Cancer Research UK LbgUnited Kingdom · 1 shared project
- Concentris Research Management GmbHGermany · 1 shared project
- Fondazione Centro San RaffaeleItaly · 1 shared project
- Fondazione Centro San Raffaele del Monte TaborItaly · 1 shared project
- Bayer Pharma AGGermany · 1 shared project
- Axcentua Pharmaceuticals ABSweden · 1 shared project
- Lab 21 LimitedUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- drug discovery
- laboratory samples analysis
- pancreatic cancer
- prostate cancer
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
